Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 29.34 | 20.80 | 17.59 | 21.69 | 12.15 | 17.60 | 11.21 | 68.95 | 11.52 | 15.66 | 13.98 | 12.63 | 23.52 | 14.58 | 19.10 | 36.28 | — | 124.82 | 17.73 | 16.65 | — |
| — | +18.2% | +56.9% | -68.5% | +5.5% | +12.4% | -19.8% | +446.1% | -51.0% | +7.4% | -26.8% | -65.2% | — | -88.3% | +7.7% | +117.9% | — | +4757.1% | +25.7% | +79.5% | — | |
| P/S Ratio | 2.32 | 2.05 | 1.65 | 1.39 | 1.24 | 1.11 | 0.97 | 1.14 | 1.45 | 1.45 | 1.23 | 1.19 | 0.85 | 0.84 | 0.83 | 0.87 | 0.90 | 1.00 | 1.01 | 0.98 | 1.01 |
| — | +84.6% | +70.5% | +21.6% | -14.1% | -23.1% | -21.6% | -4.1% | +70.4% | +72.7% | +49.1% | +37.4% | -5.9% | -16.1% | -18.3% | -11.5% | -10.5% | -8.1% | -23.0% | -4.6% | +0.5% | |
| P/B Ratio | 3.28 | 2.97 | 2.30 | 2.00 | 1.80 | 1.63 | 1.43 | 1.71 | 2.00 | 1.78 | 1.58 | 1.57 | 1.10 | 1.07 | 1.01 | 1.04 | 1.11 | 1.20 | 1.19 | 1.15 | 1.19 |
| — | +82.6% | +60.2% | +16.5% | -9.9% | -8.5% | -9.3% | +9.0% | +80.7% | +66.5% | +56.1% | +51.0% | -0.5% | -10.9% | -15.0% | -9.8% | -6.9% | +1.6% | -19.5% | -9.7% | -3.3% | |
| P/FCF | 23.65 | 27.27 | 11.90 | 83.66 | 8.42 | 7.93 | 10.91 | 90.92 | 49.13 | 9.84 | 99.25 | 20.89 | 9.50 | 7.14 | 30.89 | 36.28 | — | 14.89 | — | 138.18 | — |
| — | +243.8% | +9.1% | -8.0% | -82.9% | -19.4% | -89.0% | +335.3% | +417.0% | +37.9% | +221.3% | -42.4% | — | -52.1% | — | -73.7% | — | +3.5% | — | +723.1% | — | |
| EV / EBITDA | 20.15 | 13.86 | 13.98 | 11.81 | 11.44 | 9.59 | 9.33 | 12.00 | 16.71 | 12.79 | 13.90 | 11.11 | 10.60 | 10.16 | 12.00 | 12.56 | 18.62 | 19.91 | 12.39 | 14.36 | 12.36 |
| — | +44.5% | +49.8% | -1.5% | -31.6% | -25.0% | -32.9% | +7.9% | +57.7% | +25.8% | +15.8% | -11.5% | -43.1% | -48.9% | -3.1% | -12.5% | +50.6% | +69.4% | +0.6% | +25.1% | -10.9% | |
| EV / EBIT | 27.20 | 15.43 | 13.60 | 16.09 | 8.51 | 12.67 | 8.50 | 54.25 | 8.85 | 11.13 | 10.19 | 9.65 | 17.40 | 10.91 | 15.22 | 32.59 | — | 78.90 | 14.35 | 13.05 | — |
| — | +21.8% | +60.0% | -70.3% | -3.9% | +13.8% | -16.6% | +462.1% | -49.1% | +2.0% | -33.1% | -70.4% | — | -86.2% | +6.1% | +149.8% | — | +2939.7% | +32.0% | +82.3% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.3% | 40.7% | 38.4% | 39.7% | 39.1% | 39.6% | 39.0% | 36.6% | 37.3% | 38.2% | 38.4% | 38.0% | 36.7% | 38.0% | 37.7% | 36.6% | 36.1% | 35.5% | 36.4% | 37.2% | 36.1% |
| — | +2.9% | -1.3% | +8.5% | +4.8% | +3.7% | +1.5% | -3.8% | +1.6% | +0.5% | +1.7% | +3.8% | +1.7% | +7.1% | +3.7% | -1.7% | -0.1% | +4.5% | +5.1% | -3.1% | -1.0% | |
| Operating Margin | 8.5% | 12.0% | 8.4% | 8.6% | 7.9% | 9.1% | 8.2% | 7.2% | 6.2% | 7.7% | 5.3% | 6.7% | 4.5% | 4.9% | 3.7% | 3.4% | 1.5% | 1.7% | 5.3% | 3.4% | 4.8% |
| — | +31.9% | +2.6% | +19.1% | +28.3% | +17.6% | +56.5% | +7.6% | +37.0% | +56.3% | +41.6% | +95.1% | +199.9% | +194.6% | -29.9% | +0.6% | -68.6% | -69.8% | -20.6% | -33.6% | +62.8% | |
| Net Margin | 7.9% | 9.9% | 9.4% | 6.4% | 10.3% | 6.3% | 8.6% | 1.6% | 12.6% | 9.2% | 8.8% | 9.4% | 3.6% | 5.8% | 4.3% | 2.4% | -0.9% | 1.2% | 5.7% | 5.9% | -1.3% |
| — | +56.2% | +9.0% | +290.5% | -18.5% | -31.4% | -2.3% | -82.6% | +249.3% | +60.0% | +102.8% | +292.3% | +501.5% | +387.6% | -23.8% | -59.1% | +28.7% | -97.2% | -38.7% | -46.8% | -123.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.7% | 3.6% | 3.3% | 2.3% | 3.8% | 2.3% | 3.2% | 0.6% | 4.4% | 2.9% | 2.9% | 3.2% | 1.2% | 1.8% | 1.3% | 0.7% | -0.3% | 0.4% | 1.7% | 1.7% | -0.4% |
| — | +55.3% | +2.1% | +277.4% | -14.9% | -18.5% | +13.3% | -80.5% | +277.7% | +55.4% | +113.9% | +337.4% | +530.2% | +422.0% | -20.8% | -58.6% | +26.2% | -97.1% | -36.3% | -50.1% | -122.2% | |
| ROA | 7.9% | 2.6% | 2.4% | 1.6% | 2.5% | 1.5% | 2.1% | 0.4% | 2.9% | 2.0% | 2.0% | 2.2% | 0.8% | 1.3% | 0.9% | 0.5% | -0.2% | 0.2% | 1.1% | 1.1% | -0.2% |
| — | +72.7% | +12.2% | +307.1% | -15.1% | -24.5% | +5.2% | -82.0% | +263.7% | +57.9% | +116.0% | +343.4% | +541.6% | +440.5% | -16.8% | -55.9% | +21.2% | -96.8% | -29.1% | -45.1% | -124.3% | |
| ROIC | 8.9% | 3.4% | 2.3% | 2.4% | 2.1% | 2.3% | 2.1% | 1.8% | 1.6% | 1.9% | 1.3% | 1.7% | 1.1% | 1.1% | 0.8% | 0.7% | 0.3% | 0.3% | 1.1% | 0.7% | 1.0% |
| — | +48.1% | +12.9% | +33.5% | +36.4% | +24.1% | +59.4% | +4.5% | +44.2% | +66.4% | +63.1% | +138.5% | +244.8% | +227.5% | -26.4% | -0.2% | -68.5% | -69.8% | -19.5% | -39.2% | +53.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.08 | 0.03 | 0.04 | 0.08 | 0.12 | 0.17 | 0.20 | 0.22 | 0.23 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.17 | 0.18 | 0.18 | 0.19 |
| — | -83.5% | -82.2% | -62.9% | -48.4% | +101.3% | +117.5% | +113.0% | +104.9% | -32.2% | -30.8% | -28.5% | -24.5% | -26.8% | -23.6% | -21.8% | -21.6% | -15.2% | -24.0% | -24.5% | -25.3% | |
| Debt / EBITDA | 0.50 | 0.52 | 0.90 | 1.94 | 3.08 | 3.83 | 4.86 | 5.65 | 7.31 | 2.49 | 3.27 | 2.93 | 4.38 | 4.55 | 5.87 | 6.45 | 9.32 | 10.45 | 6.66 | 8.64 | 7.58 |
| — | -86.3% | -81.6% | -65.7% | -57.8% | +53.8% | +48.6% | +93.0% | +66.7% | -45.3% | -44.2% | -54.6% | -52.9% | -56.5% | -11.9% | -25.3% | +23.0% | +37.9% | -9.5% | +3.6% | -33.8% | |
| Current Ratio | 1.77 | 22.06 | 17.27 | 1.77 | 1.75 | 1.72 | 1.90 | 1.81 | 1.80 | 2.06 | 2.02 | 1.89 | 1.87 | 1.86 | 1.84 | 1.79 | 1.64 | 1.76 | 1.77 | 1.62 | 1.65 |
| — | +1180.1% | +807.6% | -2.2% | -2.8% | -16.5% | -5.9% | -4.6% | -3.8% | +10.7% | +9.7% | +5.9% | +14.0% | +5.9% | +4.0% | +10.3% | -0.6% | +3.1% | +1.5% | -0.2% | +1.4% | |
| Quick Ratio | 1.77 | 22.06 | 17.27 | 1.77 | 1.72 | 1.69 | 1.87 | 1.77 | 1.77 | 2.03 | 1.99 | 1.86 | 1.83 | 1.83 | 1.81 | 1.75 | 1.60 | 1.73 | 1.73 | 1.59 | 1.61 |
| — | +1202.3% | +824.0% | -0.1% | -2.6% | -16.7% | -6.1% | -4.9% | -3.7% | +11.2% | +10.2% | +6.1% | +14.2% | +5.9% | +4.2% | +10.3% | -0.6% | +2.9% | +1.0% | -0.3% | +1.0% | |
| Interest Coverage | 26.50 | 4155.54 | 167.60 | 40.38 | 38.37 | 17.14 | 21.76 | 3.58 | 34.32 | — | 777.37 | 655.73 | 183.19 | 241.03 | 161.42 | 67.19 | -30.00 | 24.64 | 125.50 | 112.91 | -37.57 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NHC stock.
National HealthCare Corporation's current P/E is 29.3x. The average P/E over the last 4 quarters is 18.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
National HealthCare Corporation's current operating margin is 8.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking National HealthCare Corporation's business trajectory between earnings reports.